Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1.
Front Oncol. 2022 Feb 17;12:828684. doi: 10.3389/fonc.2022.828684. eCollection 2022.
Front Oncol. 2022.
PMID: 35251998
Free PMC article.
Review.